Assessment of suitable areas for afforestation and its carbon sink value in fragile ecological areas of northern China.

Afforestation and reforestation are pivotal in mitigating land degradation and bolstering the carbon sink capacity of terrestrial ecosystems. However, the potential economic ramifications of afforestation and reforestation in the context of climate change remain largely unexplored. In this study, we employed an interdisciplinary methodology to establish a framework for assessing future forest potential and carbon sequestration in the Eastern Loess Plateau region of China. Our findings indicate that an estimated 17,392.99 km2 of land suitable for afforestation still existed within the region, exhibiting a propensity to aggregate around existing forests rather than being dispersed randomly. Notably, 4385.36 km2 was prioritized for afforestation initiatives. Projections suggest a significant enhancement of the forest carbon sink within the study area by 2050, ranging from 36.93 Mt to 105.38 Mt. The corresponding economic value for this enhancement is estimated to vary between US$3.25 billion and US$17.68 billion. Of significance is the observed polarization of the region's carbon sink capacity over time, with half of the total carbon sinks concentrated within 10% of the districts. Additionally, approximately 26% of the counties are expected to transition from carbon sinks to carbon sources. These findings underscore the substantial impact of climate change on forest distribution and suggest a targeted approach to combat forest degradation by circumventing ineffective afforestation activities.

Analysis of the Clinical Efficacy of Dendritic Cell -cytokine Induced Killer Cell-based Adoptive Immunotherapy for Colorectal Cancer.

Background: To analyze the efficacy and safety of dendritic cell - cytokine - induced killer (DC-CIK) immunotherapy combined with chemotherapy for colorectal cancer. Method: A retrospective analysis was conducted in 116 patients from February 2012 to December 2017, who were divided into postoperative adjuvant chemotherapy group alone, combined DC-CIK immunotherapy group, advanced cancer palliative care group, and palliative care + DC-CIK immunotherapy group, to evaluate cellular immune function, disease-free survival(DFS) and overall survival(OS). Results: In the adjuvant therapy and palliative care group, the percentages of CD3+, CD8+ and NK cells after treatment were significantly lower than before, whereas in the other two groups given DC-CIK immunotherapy, the percentages of CD3+, CD8+, NK and NKT cells after treatment were all higher than before, with a significant increase compared with the chemotherapy group (P < .05). DFS (42.4 ± 5.26 m) in the group receiving postoperative adjuvant chemotherapy + DC-CIK immunotherapy was significantly longer than that (23.5 ± 2.79 m) in the group only given postoperative adjuvant chemotherapy (P < .05). OS in the group receiving palliative care + DC-CIK immunotherapy was slightly longer than that in the group only given palliative care for advanced cancer (29 m vs 26 m, P > .05).Conclusion: Combination with DC-CIK immunotherapy could effectively improve cellular immune function. Postoperative adjuvant chemotherapy in combination with DC-CIK immunotherapy could significantly prolong DFS, but palliative care in combination with DC-CIK immunotherapy did not significantly prolong OS in patients with advanced cancer.

Acupuncture for allergic rhinitis: a systematic review and meta-analysis.

BACKGROUND: In this study, we attempted to assess the efficacy and safety of acupuncture for allergic rhinitis (AR), and to test the robustness of the estimated effects. METHODS: The Cochrane methodology standard was followed to conduct this systematic review. Randomized controlled trials (RCTs) comparing acupuncture with other therapies for AR were included. Furthermore, trial sequential analysis was conducted to test the robustness of pooled results. Thirty trials with 4413 participants were included. RESULTS: Acupuncture improved the nasal symptoms on Total Nasal Symptom Score (TNSS) and quality of life measured by Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in adults with AR, compared to acupuncture with no intervention. Acupuncture was also shown to be more effective than sham acupuncture for nasal symptom (RQLQ subscale, n = 489, MD - 0.60, 95% CI - 1.16 to - 0.04) and quality of life (RQLQ, n = 248, - 8.47 95% CI - 14.91, - 2.03). No clear difference was observed between acupuncture and cetirizine or loratadine. Interestingly, trial sequential analysis (TSA) failed to confirm the aforementioned results. The effect of acupuncture for children/adolescents with AR remains unclear due to insufficient data. The performance bias and attrition bias are serious in most studies that were included. Selection bias may also have affected the quality of the evidence. CONCLUSION: Acupuncture may have an advantage over no intervention and sham acupuncture in improving nasal symptoms and quality of life for adults with AR. The effect of acupuncture and cetirizine or loratadine for AR may be similar. Additional trials are necessary to confirm these results.

Effects of HGF and KGF gene silencing on vascular endothelial growth factor and its receptors in rat ultraviolet radiation­induced corneal neovascularization.

Hepatocyte growth factor (HGF) and keratinocyte growth factor (KGF), two paracrine growth factors, modulate corneal epithelial cell metabolism, apoptosis and survival. Vascular endothelial growth factor (VEGF) serves as a proangiogenic factor in corneal neovascularization (CNV), which is a major cause of vision impairment and corneal blindness. The aim of the present study was to evaluate the ability of HGF and KGF to influence VEGF and its receptor, kinase insert domain receptor (Flk­1) in corneal injury and CNV in rats induced by ultraviolet radiation (UVR). An UVR­induced corneal injury rat model was successfully established to characterize the expression patterns of KGF, HGF, VEGF and Flk­1 in corneal tissues. Corneal epithelial cells were extracted and treated with small interfering RNAs (siRNAs) targeting KGF, HGF or both (si­KGF, si­HGF or si­HGF/KGF). The effects of HGF and KGF were examined through detection of the expression of KGF, HGF, VEGF and Flk­1, and the evaluation of cell proliferation, cell cycle and cell apoptosis. The expression levels of KGF, HGF, VEGF and Flk­1 in corneal tissues were increased in the rat model. In the cell experiments, the transfection of si­HGF/KGF resulted in reductions in VEGF, Flk­1, KGF and HGF. In addition, decreased cell proliferation and elevated cell apoptosis were found in the corneal epithelial cells from the rat model following KGF and HGF gene silencing. Taken together, these findings suggest that HGF and KGF gene silencing inhibits UVR­induced corneal epithelial proliferation and CNV and may function as novel targets for corneal wound healing.